Mutation analysis of the checkpoint kinase 2 gene in colorectal cancer cell lines / 中华医学杂志(英文版)
Chinese Medical Journal
; (24): 2119-2123, 2007.
Article
in En
| WPRIM
| ID: wpr-255433
Responsible library:
WPRO
ABSTRACT
<p><b>BACKGROUND</b>Checkpoint kinase 2 (CHK2) is a DNA damage-activated protein kinase which is involved in cell cycle checkpoint control. CHK2 gene could be a candidate gene for colorectal cancer susceptibility. But there are few systematic reports on mutation of CHK2 in colorectal cancer.</p><p><b>METHODS</b>The mutations of all 14 exons of CHK2 in 56 colorectal cancer cell lines were screened systematically, using denaturing high-performance liquid chromatography (DHPLC) to screen the mismatches of the CHK2 exons amplified products, and then the suspected mutant cell lines were scanned by nucleotide sequence analysis.</p><p><b>RESULTS</b>VACO400 in CHK2 exon 1a was suspected to have mutation by DHPLC and confirmed by sequence, but this was nonsense mutation. C106, CX-1, HT-29, SK01, SW480, SW620 and VACO400 in CHK2 exon 1b were confirmed to have the same nonsense mutation in 11609 A > G. DLD-1 and HCT-15 in CHK2 exon 2 were confirmed to have missense mutation R145W, which was heterozygous C > T missense mutation at nucleotide 433, leading to an Arg > Trp substitution within the FHA domain.</p><p><b>CONCLUSIONS</b>The CHK2 mutation in colorectal cancer is a low frequency event. There are just 10 cell lines to have sequence variations in all the 14 exons in 56 colorectal cancer cell lines and only DLD-1/HCT-15 had heterozygous missense mutation. These findings may give useful information of susceptibility of colorectal cancer as single nucleotide polymorphysim.</p>
Full text:
1
Database:
WPRIM
Main subject:
DNA Damage
/
Colorectal Neoplasms
/
Chromatography, High Pressure Liquid
/
Protein Serine-Threonine Kinases
/
Cell Line, Tumor
/
Checkpoint Kinase 2
/
Genetics
/
Mutation
Limits:
Humans
Language:
En
Journal:
Chinese Medical Journal
Year:
2007
Document type:
Article